At a glance
ClinicalIndex Comparison RecordN/ACompleted· 8 enrolled
Drug / intervention
HDF NaCl +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of an Increased Sodium Chloride Concentration in the Infusion Fluid of Predilution Hemodiafiltration on the Removal of Protein-Bound Uremic Toxins
In Brief
A clinical study evaluating HDF NaCl, Hemodialysis, and 1 other intervention for End-stage Renal Disease. Completed, enrolled 8 participants across 1 site.
Detailed Summary
An increase of the free fraction may allow a better removal of of protein-bound uremic toxins during dialysis. During predilution hemodiafiltration, the sodium chloride (NaCl) concentration will be increased in the infusion fluid at a target NaCl concentration and the effect on the removal of protein-bound toxins will be determined. Comparisons will be made to standard hemodialysis and hemodiafiltration.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEnd-stage Renal Disease
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartAug 2013
First PostedAug 2013
Primary CompletionMar 2015
Study CompletionAug 2015
TodayJul 2026
First PostedAug 16, 2013
Enrollment StartAug 1, 2013
Primary CompletionMar 30, 2015
Study CompletionAug 10, 2015
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 12.9 years ago
Interventions
HDF NaClprocedure
Hemodialysisprocedure
Standard Predilution Hemodiafiltrationprocedure